NO20070747L - Metode for fremstilling av 2-substituerte derivater av estron og estradiol - Google Patents

Metode for fremstilling av 2-substituerte derivater av estron og estradiol

Info

Publication number
NO20070747L
NO20070747L NO20070747A NO20070747A NO20070747L NO 20070747 L NO20070747 L NO 20070747L NO 20070747 A NO20070747 A NO 20070747A NO 20070747 A NO20070747 A NO 20070747A NO 20070747 L NO20070747 L NO 20070747L
Authority
NO
Norway
Prior art keywords
compound
general formula
preparing
estrone
estradiol
Prior art date
Application number
NO20070747A
Other languages
English (en)
Norwegian (no)
Inventor
Johannes Stoelwinder
Nicolaas Elisabeth Corne Moers
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20070747L publication Critical patent/NO20070747L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20070747A 2004-08-04 2007-02-08 Metode for fremstilling av 2-substituerte derivater av estron og estradiol NO20070747L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103742 2004-08-04
PCT/EP2005/053732 WO2006013196A1 (en) 2004-08-04 2005-08-01 Process for the preparation 2-substituted-derivatives of estrone and estradiol

Publications (1)

Publication Number Publication Date
NO20070747L true NO20070747L (no) 2007-04-23

Family

ID=34929415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070747A NO20070747L (no) 2004-08-04 2007-02-08 Metode for fremstilling av 2-substituerte derivater av estron og estradiol

Country Status (20)

Country Link
US (2) US7910756B2 (de)
EP (1) EP1776378B1 (de)
JP (1) JP5075626B2 (de)
KR (1) KR20070040386A (de)
CN (1) CN1993376A (de)
AR (1) AR050195A1 (de)
AT (1) ATE447580T1 (de)
AU (1) AU2005268768B2 (de)
BR (1) BRPI0514096A (de)
CA (1) CA2573133C (de)
DE (1) DE602005017500D1 (de)
EC (1) ECSP077228A (de)
ES (1) ES2334244T3 (de)
IL (1) IL180381A0 (de)
MX (1) MX2007001340A (de)
NO (1) NO20070747L (de)
RU (1) RU2007107914A (de)
TW (1) TW200611909A (de)
WO (1) WO2006013196A1 (de)
ZA (1) ZA200700483B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300376B6 (cs) 2008-05-05 2009-05-06 Prírodovedecká Fakulta Uk Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
WO2012020417A1 (en) 2010-08-10 2012-02-16 Reliance Life Sciences Pvt. Ltd. Process for the preparation of estradiol and its derivatives
ES2671238T3 (es) * 2011-08-12 2018-06-05 Siemens Healthcare Diagnostics Inc. Detección de esteroides sexuales
CN104592339A (zh) * 2014-12-30 2015-05-06 湖南新合新生物医药有限公司 雌甾-4,9-二烯-3,17-二酮的制备方法
CN104497088B (zh) * 2014-12-30 2016-08-24 湖南新合新生物医药有限公司 19-去甲-4-雄甾烯-3,17-二酮的制备方法
ITUB20155260A1 (it) * 2015-10-30 2017-04-30 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one
CN108003210A (zh) * 2018-01-24 2018-05-08 四川理工学院 一种雌甾-4,9-二烯-3,17-二酮的制备方法
CN108997463B (zh) * 2018-08-09 2021-05-14 四川理工学院 一种雌甾-4，9-二烯-3，17-二酮制备方法
CN112409434B (zh) * 2020-11-27 2021-10-26 厦门欧瑞捷生物科技有限公司 一种去氢孕酮的合成方法
CN113861158B (zh) * 2021-11-22 2023-02-10 湖南新合新生物医药有限公司 一种合成甲基双烯双酮关键中间体的方法
CN114853802B (zh) * 2022-03-22 2023-11-28 河北康泰药业有限公司 一种谷内酯衍生物及其制备方法、药物组合物和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997488A (en) * 1959-06-20 1961-08-22 Organon 2-methyl-19-nor-steroids
FR1468608A (fr) * 1960-08-04 1967-02-10 Upjohn Co 2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention
BE616293A (fr) 1961-04-14 1962-10-11 Roussel Uclaf Dérivés de la 19-nor testostérone et procédé de préparation
FR1368721A (fr) * 1961-04-14 1964-08-07 Roussel Uclaf Dérivés de la 19-nor testostérone et procédé de préparation
US3519714A (en) 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
US4400524A (en) 1981-07-28 1983-08-23 The Upjohn Company Grignard reagents prepared from 5-halopentan-2-one propylene ketals
DE3208432A1 (de) * 1982-03-09 1983-09-15 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
US5998639A (en) 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
IL119649A (en) 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
US6051726A (en) 1997-03-13 2000-04-18 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
AU7572600A (en) 1999-08-23 2001-03-19 Entremed, Inc Methods of obtaining 2-methoxyestradiol of high purity
AU8838601A (en) 2000-11-27 2002-06-03 Entremed Inc Antiangiogenic agents

Also Published As

Publication number Publication date
JP2008509109A (ja) 2008-03-27
AU2005268768A1 (en) 2006-02-09
AR050195A1 (es) 2006-10-04
ECSP077228A (es) 2007-03-29
US20110152544A1 (en) 2011-06-23
EP1776378A1 (de) 2007-04-25
US7910756B2 (en) 2011-03-22
CA2573133A1 (en) 2006-02-09
US20090012319A1 (en) 2009-01-08
CN1993376A (zh) 2007-07-04
IL180381A0 (en) 2007-06-03
MX2007001340A (es) 2007-03-27
ZA200700483B (en) 2008-09-25
DE602005017500D1 (de) 2009-12-17
RU2007107914A (ru) 2008-09-10
ES2334244T3 (es) 2010-03-08
AU2005268768B2 (en) 2011-10-13
ATE447580T1 (de) 2009-11-15
CA2573133C (en) 2012-07-10
JP5075626B2 (ja) 2012-11-21
KR20070040386A (ko) 2007-04-16
WO2006013196A1 (en) 2006-02-09
BRPI0514096A (pt) 2008-05-27
TW200611909A (en) 2006-04-16
EP1776378B1 (de) 2009-11-04

Similar Documents

Publication Publication Date Title
NO20070747L (no) Metode for fremstilling av 2-substituerte derivater av estron og estradiol
CA1334668C (en) 13-alkyl-11beta-phenylgonanes
AU2001253427B2 (en) A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
WO2005105822A3 (en) 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
DK172935B1 (da) Fremgangsmåde til fremstilling af C-20-amino-substituerede makrolid-derivater
Di Matteo et al. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl) piperidine sulfonamides as aromatase inhibitors
TW200722086A (en) Compounds comprising an oxazole or thiazole moiety, processes for making them and their uses
FR2618783A1 (fr) Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
KR20180030204A (ko) 담즙산 및 이의 유도체를 제조하는 방법
DE1618830A1 (de) Verfahren zur Herstellung von in 11-Stellung substituierten Steroidderivaten mit aromatischem Kern A
Mizoguchi et al. Synthesis of multiply substituted 1, 6-dihydropyridines through Cu (I)-catalyzed 6-endo cyclization
Quindt et al. Photo-Fries rearrangement of some 3-acylestrones in homogeneous media: preparative and mechanistic studies
HU222015B1 (hu) Benzopiránvegyületek előállítási eljárásaiban felhasználható intermedierek és eljárás a köztitermékek előállítására
AU2014300894A1 (en) Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase
WO2010141494A2 (en) Synthesis of ezetimibe
Haveli et al. Ring opening of activated cyclopropanes with NIS/NaN3: synthesis of C-1 linked pseudodisaccharides
Frank et al. Synthesis of some novel D-ring-fused dioxa-and oxazaphosphorinanes in the estrone series
EP0087359B1 (de) Reagenz zur Nitromethylierung, seine Anwendung zur Herstellung von nitromethylierten Verbindungen von bestimmten Derivaten davon und die erhaltenen Verbindungen
RS20050310A (en) Process for preparing 7-carboxy substituted steroids
EP0567472A1 (de) D-homo-(16-en)-11 beta-aryl-4-estrene,verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel.
EP1743902A1 (de) Verfahren zur herstellung eines 5-alpha-prägnanderivats
Williams et al. Synthesis of the aglycone of 26-O-deacetyl pavoninin-5
Zhang et al. A convenient synthesis of novel aza-C-disaccharide analogues
Zhuang et al. Synthesis of Novel Oximes of 2‐Aryl‐6‐methoxy‐3, 4‐dihydronaphthalene and Their Evaluation as Inhibitors of 17α‐Hydroxylase‐C17, 20‐Lyase (P450 17)
JP2007131558A (ja) アセトキシキャビコールアセテート類縁体化合物、その製造方法、および抗アレルギー剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application